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Abstract
Background: Dietary reference values for folate intake 
vary widely across Europe. Methods: MEDLINE and Embase 
through November 2016 were searched for data on the as-
sociation between folate intake and biomarkers (serum/
plasma folate, red blood cell [RBC] folate, plasma homocys-
teine) from observational studies in healthy adults and el-
derly. The regression coefficient of biomarkers on intake (β) 
was extracted from each study, and the overall and strati-
fied pooled β and SE (β) were obtained by random effects 
meta-analysis on a double log scale. These dose-response 
estimates may be used to derive folate intake reference val-
ues. Results: For every doubling in folate intake, the chang-
es in serum/plasma folate, RBC folate and plasma homocys-
teine were +22, +21, and –16% respectively. The overall 
pooled regression coefficients were β = 0.29 (95% CI 0.21–
0.37) for serum/plasma folate (26 estimates from 17 stud-
ies), β = 0.28 (95% CI 0.21–0.36) for RBC (13 estimates from 
11 studies), and β = –0.21 (95% CI –0.31 to –0.11) for plasma 
homocysteine (10 estimates from 6 studies). Conclusion: 
These estimates along with those from randomized con-
trolled trials can be used for underpinning dietary recom-
mendations for folate in adults and elderly.
© 2018 S. Karger AG, Basel
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Introduction
Adequate folate intake is necessary to achieve and 
maintain optimal health in all life stages. Folate deficien-
cies can result in many health problems, such as neural 
tube defects in developing embryos, and may lead to an 
increased risk of cardiovascular disease, anemia, cogni-
tive impairment, and depression among adults and el-
derly [1–3]. Dietary reference values provide guidance on 
optimal dietary folate intake that should prevent deficien-
cy and development of health problems. 
The EURopean micronutrient RECommendations 
Aligned network (EURRECA; http://www. eurreca.org) 
has been developing approaches to derive and update 
micronutrient reference values, including folate. This 
process requires reliable data on the association between 
folate intake, status and health outcomes, which would 
allow estimating the intakes to achieve preset concentra-
tions of relevant biomarkers. The EURRECA network 
has proposed 3 biomarkers of folate status: plasma or 
serum folate, red blood cell (RBC) folate, and plasma 
homocysteine (tHcy) [4]. A meta-analysis on dose-re-
sponse relation between folic acid intake and plasma 
biomarkers from randomized controlled trials (RCTs) 
in adults and elderly has been recently investigated by 
EURRECA coworkers [3]. We now performed a system-
atic review that included data from observational studies 
in which folate intake represents intakes from its natural 
dietary matrix and from fortified foods and supple-
ments, and in which populations are not confined to 
those strictly selected by the RCTs inclusion and exclu-
sion criteria [5, 6]. This study fills a knowledge gap by 
systematically reviewing all available observational 
studies that investigated the relationship between folate 
intake and biomarkers of folate status in adults and el-
derly, followed by meta-analyses in order to model bio-
markers of folate status as a function of dietary folate 




Within the EURRECA framework, systematic reviews were 
performed to explore the associations between intakes, status, 
and selected health outcomes for the public health priority micro-
nutrients (iron, zinc, folate, vitamin B12, and iodine) [7–9]. This 
process followed a harmonized search strategy, aimed to collect 
the  data published up to and including November 2016 using 
Medline  and Embase search terms for (“study designs in 
 humans”)  AND (folate or folic acid or vitamin B9) AND (in-
take OR status),  retrieved on Ovid Platform. Both indexing and 
text  terms were used and languages included were restricted 
to  those spoken in the  EURRECA Network (English, Dutch, 
French, German,  Hungarian, Italian, Norwegian, Polish, Spanish, 
Greek, and  Serbian). The summary of the general search strategy 
developed for a search in EMBASE (on Ovid Platform) is shown 
in Table 2. Search strategies for MEDLINE (on Ovid Platform) 
were adapted based on this strategy. The reference lists of retrieved 
articles and published reviews were also checked for relevant stud-
ies. Where necessary, authors were contacted to provide missing 
data or clarify methods or results.
Study Selection
For a study to be included, it had to meet all of the following 
inclusion criteria: designed as prospective cohort, nested case-
control or cross-sectional study in apparently healthy adults and 
elderly; it had to report on both dietary folate intake and status 
following the EURRECA guidance on best practice micronutrient 
intake and status method [9]; folate intake was measured with a 
validated food frequency questionnaire (FFQ), a dietary history, 
or a 24-h recall (24HDR) or a food record/diary (FR); folate status 
was reported as plasma or serum folate, RBC folate, or total plas-
ma homocysteine a non-specific marker of folate status.
Studies were excluded if they were retrospective cohort studies, 
or non-nested case-control studies, performed in non-healthy or 
populations other than adults and elderly, or were commentaries, 
reviews, or duplicate publications from the same study.
Of 7,249 identified articles in the wider search on folate intake, 
status and priority health outcomes in all populations, 7,049 were 
excluded following the screening of the title and abstract. The re-
maining 200 full-text articles were screened by 2 independent re-
viewers (R.N. and M.N.) and all discrepancies on study inclusion 
were discussed. This process resulted in 45 potentially relevant pa-
pers, out of which 23 were identified for the final analysis, in addi-
tion to 1 paper that was identified by following up on reference lists 
of the articles that were included into this review. Papers with in-
complete data that could not be obtained from the authors were 
excluded. The flow diagram of the articles screened, assessed, and 
excluded at various stages is shown in Figure 1.
Data Extraction
For each of the identified manuscripts, data were extracted into 
a standardized database. This was done by one (R.N.) and checked 
by another reviewer (M.N.).
Extracted data included population characteristics, mean, and 
SD of folate intake and dietary assessment method, concentrations 
of folate related biomarkers and analytical method used to mea-
sure folate status, the association and type of association between 
folate intake and folate-related biomarkers (Spearman rank cor-
relation coefficient, Pearson correlation coefficient, linear regres-
sion coefficient), and information on any transformations applied 
to obtain the reported associations. Serum/plasma folate concen-
trations were converted to μmol/L when applicable. 
In order to assess the quality of the included studies and the risk 
of bias, indicators of internal validity were collected during data 
extraction. Based on the indicators, 2 independent reviewers as-
sessed the overall risk of bias and disagreements resolved by dis-
cussion. The criteria for judging these indicators were adapted 
from the Cochrane Library [10]. Table 3 presents the characteris-
tics of the included studies [11–34].
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Data Synthesis
Each study provided at least one independent estimate; for some 
studies, 2 or 3 estimates were obtained because of stratification by 
gender [20, 25], by genotype [15, 17], by race [29, 32], or by diet 
type [23]. Where data on folate intake and status were available for 
males and females separately, but there was only one estimate of the 
association [13, 16, 25, 27]; the pooled estimates of mean folate in-
take and status were calculated and used in the analysis.
Statistical Analysis
The intake-status relationship was assumed to be linear with a 
coefficient between –1 and +1 on the loge–loge scale (natural loga-
rithm of dependent and independent variable). Positive values 
would translate to a monotonic concave curve on the arithmetic 
scale that steeply increases at low intakes and less so at higher lev-
els, which is a common shape in biology [6, 35].
Assuming this model, summary statistics from each study were 
transformed into estimates of the dose-response relationship: a re-
gression coefficient (β) and its standard error (SE [β]) of micronu-
trient status on micronutrient intake. The individual estimates of 
the dose-response regression coefficients were combined into an 
overall pooled β and SE (β) by means of random effects meta-anal-
ysis, which incorporates the between-study variation using the 
method of DerSimonian and Laird [36] to obtain the weights re-
quired for the summary estimate. Residual heterogeneity between 
studies was evaluated using the I2 statistic. We investigated the in-
take-status relationship for each of the 3 biomarkers separately. In 
addition, we investigated whether mean age (continuous), dietary 
intake method (categories: [i] FFQ, and [ii] 24HDR or FR), and fo-
late matrix (categories: [i] folate from the diet, [ii] folate from the 
diet and supplements), and analytical method used to measure fo-
late status (categories: [i] microbiological assay, [ii] non microbio-
logical assay) were variables that modified the association using 
meta-regression. Statistical transformations to obtain β and SE (β) 
were performed using GenStat version 13-SP2 (VSN International 
Ltd., http://www.vsni.co.uk/) and the meta-analysis was performed 
using STATA version 10.0 (College Station, TX, USA), with statis-
tical significance defined as p < 0.05.
All studies that were included in this review were assessed for 
study quality by following the Cochrane Handbook. It was checked 
if these studies dealt with confounding factors adequately, whether 
assessment of exposure (intake or status) and funder were ade-
Table 1. PICOS criteria used to define the research question for the systematic review
Criteria Description
Population Apparently healthy adults and elderly
Intervention Folate intake from diet and supplements
Comparison group The relationship between dietary folate intake and biomarkers of folate status: serum/plasma folate, 
red blood cell folate and/or plasma homocysteine
Outcomes The overall and stratified regression coefficient of biomarkers of status on dietary folate intake
Study design Observational studies
Table 2. Summary of the EURRECA general search strategy including the search terms specific for folate, developed for a search in 
 EMBASE (Ovid)
Category Search criteria
#1 Study design in humans – Cohorts
– Systematic reviews
– Cross-sectional
#2 Intake OR status – Supplementation/or diet supplementation/or dietary intake/or exp diet restriction/or exp 
mineral intake/or infant nutrition/or artificial milk/or breast milk/or bottle feeding/or 
breast feeding/or lactation/OR
– Exp nutritional status/or nutritional deficiency/or exp folate  deficiency/or exp folate blood
level/OR
– (Intake* or diet* or supplement* or deplet* or status or concentration* or expos* or fortif* 
or plasma or serum or “red blood cell*” or red blood cell or RBC or RCF or plasma 
homocysteine or hcy).ti, ab.
#3 Micronutrient Folate or folic acid or vitamin B9
#1 AND #2 AND #3
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quate, and if there were other potential threats to validity (online 
suppl. Table 1, see www.karger.com/doi/10.1159/000490003). Ev-
ery study was assigned judgments such as “high,” “moderate,” or 
“low” risk for the purpose of study quality categorization. A con-
sensus on the judgments was reached following discussion of each 
study. Thirteen studies [12, 15, 17, 19–25, 27, 30, 31] were judged 
at adequate risk of bias, 6 studies [14, 16, 18, 26, 29, 32, 34] were 
judged at a moderate risk of bias, and 4 studies was judged at a high 
risk of bias [11, 13, 28, 33].
Results
Serum/Plasma Folate
We identified 26 estimates from 17 observational stud-
ies of folate intake and serum/plasma folate status that 
were eligible for our meta-analysis. Two papers reported 
results separately for 3 different genotypes, 1 paper re-
ported results separately for 3 diet types, and 3 papers re-
ported results for males and females separately. In total, 
8,344 subjects were included with mean ages ranging 
from 21 to 65 years and sample sizes that ranged from 53 
to 1,275 participants (Table 3). Most associations were 
obtained from cross-sectional analyses (n = 18), although 
some were derived from nested case-control studies (n = 
6) and from a prospective cohort study (n = 1).
Combining these estimates in one meta-analysis yield-
ed an overall pooled beta-coefficient of β = 0.29 (95% CI 
0.21–0.37; I2 = 92.2%; Fig. 2) [11–27]. So, for studies in 
the range 152–662 µg/day, doubling of a folate intake re-
sulted in an increase in serum/plasma folate by 2β or 22% 
(20.29 = 1.22). Thus, for example, an average person with 
a folate intake of 100 µg/day has a serum/plasma folate 
status concentration that is 22% higher than a person who 
has a folate intake of 50 µg/day, or an average person with 
a folate intake of 200 µg/day has a serum/plasma folate 
status concentration that is 22% higher than a person who 
has a folate intake of 100 µg/day.
As the estimates showed substantial heterogeneity be-
tween the studies, the meta-analysis was subsequently 
stratified for folate matrix and dietary intake method. 
Stratification according to the matrix of provided folate 
(categories: [i] folate from the diet, [ii] folate from the 
diet and supplements, whether or not converted to di-
etary folate equivalents) yielded significantly different 
estimates of β = 0.33 (95% CI 0.22–0.44; n = 16) for di-
etary folate and β = 0.22 (95% CI 0.12–0.33; n = 10) for 
dietary folate plus supplements (Fig. 2). This difference 
was not statistically significant (p = 0.20) and the hetero-
geneity within the strata remained high (I2 = 92.3 and 
86.6%). 
n = 7,249 total records identified through database searching
n = 7,049 excluded: not original research paper; no prospective cohort, nested
case-control or cross-sectional study; no folate assessment; not relevant study
population; no I-S data; title or abstract only; duplicate publication; other
language   
n = 200 full-text articles obtained and screened for inclusion and exclusion criteria
n = 155 excluded with reasons:
• Not appropriate study design (n = 17)
• Performed in children, pregnant/lactating women or patients (n = 18)
• Folate dietary intake marker not appropriate (n = 39)
• Folate status marker not appropriate (n=6)
• No I-S association reported (n = 49)
• I-S association not clear or not obtained from authors upon request (n = 26)




lists   
n = 22 excluded with reasons:
• Folate dietary intake marker not appropriate (n =14)
• Folate status marker not appropriate (n = 3)
• I-S association unclear (n = 5) 
n = 24 final number of observational studies (n = 24) included in this systematic review
Fig. 1. Flow diagram of the study selection 
process for the dose-response meta-analy-
sis between folate intake and status bio-
markers in adults and elderly. I, intake; S, 
status, referring to a biomarker of intake.
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Table 3. General characteristics of the included observational studies in adults and elderly reporting the association between folate  intake 
and the biomarkers of folate status: plasma or serum folate, red blood cell folate, and plasma homocysteine









Plasma or serum folate
Arnaud et al. [11], 2001 106 M 39 152.0 Diet Food record (7 days) Protein-binding assay
Ashfield-Watt et al. [12], 2003 133 M&F 41 242.0 Diet FFQ Protein-binding assay
Chew et al. [13], 2010 100 M&F 28 296.0 Diet 1 × 24HDR Microbiological assay*
Colic Baric et al. [14], 2009 99 F 53 252.6 Diet and supplements1 FFQ Ion-capture-assay
de Bree et al. [15], 2003, CC genotype 938 M&F 41 205.0 Diet FFQ Lact. caseimicrob. assay*
de Bree et al. [15], 2003, CT genotype 907 M&F 41 203.0 Diet FFQ Lact. caseimicrob. assay*
de Bree et al. [15], 2003, TT genotype 206 M&F 41 201.0 Diet FFQ Lact. caseimicrob. assay*
Drogan et al. [16], 2004 363 M&F 52 226.9 Diet and supplements1 FFQ Ion-capture-assay
Fukuda et al. [17], 2004, CC genotype 199 M&F 65 308.0 Diet FFQ Auto-analyzer
Fukuda et al. [17], 2004, CT genotype 274 M&F 65 307.0 Diet FFQ Auto-analyzer
Fukuda et al. [17], 2004, TT genotype 81 M&F 62 299.0 Diet FFQ Auto-analyzer
Glyn et al. [18], 1996 249 M 60 320.0 Diet and supplements FFQ Radioassay
Johansson et al. [19], 2010, males 96 M 45 196.0 Diet and supplements 10 × 24HDR Radioassay
Johansson et al. [19], 2010, females 99 F 45 181.0 Diet and supplements 10 × 24HDR Radioassay
Melse-Boonstra et al. [20], 2002, males 1,275 M 41 232.0 Diet FFQ Microbiological assay*
Melse-Boonstra et al. [20], 2002, females 1,160 F 41 186.0 Diet FFQ Microbiological assay*
Sedjo et al. [21], 2002 179 F 27 418.6 Diet and supplements FFQ Radioassay
Shuaibi et al. [22], 2008 70 F 21 447.9 Diet and supplements1 Food record (3 days) Radioassay
Shupbach et al. [23], 2015, Omn 100 M&F 32 281.0 Diet Food record (3 days) Microbiological assay*
Shupbach et al. [23], 2015, Vgn 53 M&F 30 662.0 Diet and supplements Food record (3 days) Microbiological assay*
Shupbach et al. [23], 2015, Vgt 53 M&F 31 368.0 Diet Food record (3 days) Microbiological assay*
Sivaprasad et al. [24], 2016 276 M&F 47 166.0 Diet and supplements 3 × 24HDR Radioassay
Van Guelpen et al. [25], 2009, males 704 M 51 249.0 Diet and supplements FFQ Radioassay
Van Guelpen et al. [25], 2009, females 293 F 60 249.0 Diet and supplements FFQ Radioassay
Verkleij-Hagoort et al. [26], 2007 53 F 32 177.0 Diet FFQ EDTA Hemat. Anal.
Weinstein et al. [27], 2008 278 M 58 330.7 Diet FFQ Radioassay
Red blood cell folate
Chew et al. [13], 2010 100 M&F 28 296.0 Diet 1 × 24HDR Microbiological assay*
Colic Baric et al. [14], 2009 99 F 52 252.6 Diet and supplements1 FFQ Ion-capture-assay
Drogan et al. [16], 2004 363 M&F 52 226.9 Diet and supplements1 FFQ Ion-capture-assay
Fayet et al. [28], 2010 53 F 22 383.0 Diet 3 × 24HDR Chemiluminescent assays
Fraser et al. [29], 2016, B 373 M&F 56 469.0 Diet and supplements 6 × 24HDR Chemiluminescent assays
Fraser et al. [29], 2016, NB 462 M&F 61 592.0 Diet and supplements 6 × 24HDR Chemiluminescent assays
Hoey et al. [30], 2007 439 M&F 62 250.3 Diet Food diary (4 days) Microbiological assay*
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Stratification for dietary intake method yielded differ-
ent estimates for FFQs (β = 0.33, 95% CI 0.22–0.43; n = 
17) and 24HDR or FR (β = 0.18, 95% CI 0.10–0.25; n = 9), 
although this may be attributed to chance, as the differ-
ence was not statistically significant (p = 0.19). The be-
tween-study heterogeneity (I2) remained high in the FFQ 
subgroup: it was 93.8% and moderate within 24HDR and 
FR – it was 38.7%.
Stratification for the analytical method used to mea-
sure serum/plasma folate (categories: [i] microbiologi-
cal assay, [ii] non microbiological assay) yielded statisti-
cally different estimates of β = 0.51 (95% CI 0.37–0.64; 
n = 9) for microbiological assay and β = 0.18 (95% CI 
0.14–0.22; n = 17) for non-microbiological assay (p < 
0.0001). Studies that assessed serum/plasma folate re-
sponse using the microbiological assay yielded some-
what higher heterogeneity (I2 = 87.3%) compared to 
studies that assessed folate response using non-microbi-
ological assays (I2 = 49.2%).
The mean age of the study participants (continuous 
variable) was not a statistically significant determinant of 
the overall association (p = 0.52).
RBC Folate
We identified 11 observational studies of folate intake 
and RBC folate status that were eligible for our meta-anal-
yses of which 4 also provided data on serum/plasma folate 
status. As 2 papers reported results by race separately, a to-
tal of 13 estimates were available for RBC folate, including 
a total of 3,997 subjects with mean age from 22 to 86 years, 
and sample sizes ranging from 53 to 760 subjects (Table 3). 
All studies were cross-sectional except 2 that dealt with pro-
spective cohorts [32, 33], from which cross-sectional base-
line data were used. Combining the 13 estimates in one me-
ta-analysis yielded an overall pooled beta-coefficient β = 
0.28 (95% CI 0.21–0.36; I2 = 88.1%; Fig. 3) [13, 14, 16, 26, 
28–34]. So, for studies in the range from 177 to 592 µg/day 
for every doubling in folate intake, the increase in RBC fo-









Hopkins et al. [31], 2015 760 M&F 47 343.2 Diet and supplements1 Food diary (4 days) Microbiological assay*
Knutsen et al. [32], 2001, NHB 97 M&F 47 306.6 Diet 8 × 24HDR Radioimunoassay
Knutsen et al. [32], 2001, NHW 96 M&F 53 372.7 Diet 8 × 24HDR Radioimunoassay
Mendoca et al. [33], 2016 732 M&F 86 209.0 Diet 2 × 24HDR Chemiluminescent assays
Owens et al. [34], 2007 370 M&F 44 524.0 Diet and supplements1 FFQ Chemiluminescent assays
Verkleij-Hagoort et al. [26], 2007 53 F 32 177.0 Diet FFQ EDTA Hemat. Anal.
Plasma homocysteine
Chew et al. [13], 2010 100 M&F 28 296.0 Diet 1 × 24HDR HPLC
Colic Baric et al. [14], 2009 99 F 53 252.6 Diet and supplements1 FFQ Fluor. Polar. Imm.
de Bree et al. [15], 2003, CC genotype 938 M&F 41 205.0 Diet FFQ Protein-bound assay
de Bree et al. [15], 2003, CT genotype 907 M&F 41 203.0 Diet FFQ Protein-bound assay
de Bree et al. [15], 2003, TT genotype 206 M&F 41 201.0 Diet FFQ Protein-bound assay
Fukuda et al. [17], 2004, CC genotype 199 M&F 65 308 Diet FFQ Auto-analyzer
Fukuda et al. [17], 2004, CT genotype 274 M&F 65 307 Diet FFQ Auto-analyzer
Fukuda et al. [17], 2004, TT genotype 81 M&F 62 299 Diet FFQ Auto-analyzer
Van Guelpen et al. [25], 2009 293 F 60 249.0 Diet and supplements FFQ Immunoassay
Weinstein et al. [27], 2008 278 M 58 330.7 Diet FFQ HPLC
1 Study that reported total folate intake as folate from diet and supplements converted into dietary folate equivalents DFE/day, other studies reported folate in µg/day.
* Microbiological assays.
n, number of subjects; M, males; F, females; 24HDR, 24 h diet recall; FFQ, food frequency questionnaire; Omn, omnivores; Vgt, vegetarians; Vgn, vegans; B, black; NB, 
non-black; NHB, nonhispanic blacks; NHW, nonhispanic whites; Lact. casei microb. assay, lactobacillus casei microbiological assay; EDTA Hemat. Anal., ethylene-diami-
ne-tetra-acetate hematological analyses; Fluor. Polar. Imm., fluorescence polarization immunoassay; HPLC, high pressure liquid chromatography.
Table 3. (continued)
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late concentration is 2β or 21% (20.28 = 1.21). Stratifying the 
analysis for the matrix of provided folate (categories: [i] fo-
late from the diet, [ii] folate from the diet and supplements) 
yielded different estimates (β = 0.31, 95% CI 0.17–0.45, n = 
6 and β = 0.27, 95% CI 0.17–0.36, n = 7 respectively), al-
though they did not differ significantly and heterogeneity 
remained high (I2 = 75.7 and 92.3%, respectively; Fig. 3). 
Stratifying the analysis for the dietary intake method (cat-
egories: [i] FFQ and [ii] 24HDR or FR) yielded estimates of 
β = 0.16, 95% CI 0.12–0.19 (n = 4 estimates) for FFQ, and 
β = 0.33, 95% CI 0.25–0.41 (n = 9 estimates) for 24HDR or 
FR, and reduced the between-study heterogeneity in the 
FFQ subgroup, but not in the latter subgroup (I2 = 0 and 
82.3% respectively). Stratification for analytical method 
used to measure RBC folate yielded similar estimates of β = 
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Fig. 2. Random effects meta-analysis of the association between 
dietary folate and serum/plasma folate in adults and elderly, strat-
ified for the matrix of provided folate. The regression coefficients 
(β) represent the linear association between loge transformed fo-
late intake and loge transformed serum/plasma folate status (lines 
represent the confidence intervals of each study). “Dietary folate” 
shows natural food folate expressed in μg/day in all studies; “Di-
etary folate including folic acid” shows natural food folate plus 
folic acid from supplements and fortified foods expressed in μg/
day in all studies, except 3 in which it was expressed in DFE [14, 
16, 22] (Table 3).
Systematic Review of Observational 
Studies with Dose
37Ann Nutr Metab 2018;73:30–43
DOI: 10.1159/000490003
β = 0.27 (95% CI 0.19–0.35; n = 10) for non-microbiological 
assay (p = 0.77). This subgroup analyses did not substan-
tially reduce heterogeneity: I2 = 92.4 and 82.1% for micro-
biological and non-microbiological assay respectively. 
Each of these potential sources of heterogeneity (dietary 
matrix, dietary intake method, and analytical method used 
to measure RBC folate) was evaluated continuously and si-
multaneously in a meta-regression model. The results 
showed that none of the potential sources of heterogeneity, 
namely, the dietary intake method (p = 0.20), the matrix of 
provided folate (p = 0.95), analytical method used to mea-
sure RBC folate (p = 0.87), and the mean age of the study 
participants (continuous variable; p = 0.51) were statisti-
cally significant determinants of the overall beta.
Plasma Homocysteine
We identified 6 observational studies of folate intake 
and plasma homocysteine status that were eligible for our 
meta-analyses; these studies also gave information on se-
rum/plasma folate status. Two papers reported results sep-
arately for 3 different genotypes. In total, we had 10 esti-
mates for plasma homocysteine including a total of 3,375 
subjects with mean age from 28–65 years, and with sample 
sizes ranging from 81 to 938 subjects (Table 3). All studies 
were cross-sectional. Combining the 6 observational stud-
ies yielded an overall pooled beta of β = –0.21 (95% CI –0.31 
to β = –0.11; I2 = 90.5%; Fig. 4) [13–15, 17, 25, 27]. Thus, for 
studies in the range from 201 to 331 µg/day, a doubling of 
folate intake goes together with a difference in plasma ho-
mocysteine concentration of 2β (2–0.26 = 0.84), which 
is –16%. Stratifying the analysis for the matrix of provided 
folate (categories: [i] folate from the diet, [ii] folate from the 
diet and supplements) yielded different estimates (β = 
–0.23, 95% CI –0.37 to –0.10 [n = 8 estimates] and –0.13, 
95% CI –0.18 to –0.07 [n = 2 estimates] respectively Fig. 4). 
They did not differ significantly (p = 0.58) and the hetero-
geneity was reduced only in the latter subgroup (I2 = 0%), 
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Fig. 3. Random effects meta-analysis of the association between di-
etary folate and red blood cell (RBC) folate in adults and elderly, 
stratified for the matrix of provided folate. The regression coeffi-
cients (β) represent the linear association between loge transformed 
folate intake and loge transformed RBC folate status (lines represent 
the confidence intervals of each study). “Dietary folate” shows natu-
ral food folate expressed in μg/day in all studies; “Dietary folate in-
cluding folic acid” shows natural food folate plus folic acid from sup-
plements and fortified foods expressed in μg/day in one study [26], 
whereas in others it was expressed in DFE [14, 16, 34] (Table 3).
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The mean age of the study participants (continuous 
variable) was a statistically significant determinant of the 
overall association (p = 0.004).
We did not perform stratified meta-analyses or meta-
regression for the dietary intake method and total homo-
cysteine because of the small number of studies in one of 
the strata. Also, stratified meta-analyses or meta-regres-
sion for the analytical method was not possible, as all 
studies used non-microbiological assay to determine 
plasma homocysteine levels.
The association between total folate intake (folic acid 
from supplements and/or fortified foods plus dietary fo-
late) and its biomarkers in plasma/serum, RBCs, and 
plasma homocysteine levels in adults and elderly, strati-
fied by folate matrix for plasma/serum, RBCs, and plas-
ma homocysteine, and by dietary intake method and 
analytical method used to measure folate status bio-
marker for plasma/serum and RBCs is summarized in 
Table 4.
Discussion
This systematic review gives a summary of available 
observational data on the association between folate in-
take and its biomarkers for adults and elderly. It uses best 
quality evidence from a large number of subjects with a 
broad range of folate intakes as from natural settings, and 
focuses on EURRECA proposed best practice biomarkers 
of folate status [5]. The main association found by pool-
ing data from observational studies showed that total fo-
late intake (i.e., folic acid plus dietary folate) in the range 
of 152–662 μg/day is significantly associated with folate 
status biomarkers: serum/plasma folate, RBC folate, and 
total plasma homocysteine concentrations in adults and 
elderly. For every doubling in folate intake, the changes 
in serum/plasma folate, RBC folate, and plasma homo-
cysteine were +22, +21, and –16% respectively. This in-
formation, along with estimates from RCTs [3] can be 
used to decide what dose of folate or folic acid to recom-
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Fig. 4. Random effects meta-analysis of the association between 
dietary folate and plasma homocysteine folate in adults and elder-
ly, stratified for the matrix of provided folate. The regression coef-
ficients (β) represent the linear association between loge trans-
formed folate intake and loge transformed plasma homocysteine 
folate status (lines represent the confidence intervals of each 
study). “Dietary folate” shows natural food folate expressed in μg/
day in all studies; “Dietary folate including folic acid” shows natu-
ral food folate plus folic acid from supplements and fortified foods 
expressed in μg/day in one study [25], whereas in another [14] it 
was expressed in DFE (Table 3).
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For the interpretation of the results, it should be ac-
knowledged that the studies included in this meta-analysis 
differed in terms of study populations and methods. For 
serum/plasma folate and RBC folate, the mean age was not 
a clear predictor of the association. Although the folate 
food matrix (for all 3 biomarkers), dietary assessment 
method (for RBC folate), and analytical method used to 
measure the folate status (for serum/plasma folate and 
RBC folate) affected the dose-response relationship, this 
explained only part of the large heterogeneity (I2 ranged 
from 88 to 92%) between the studies. Regarding the food 
matrix, we observed a stronger association for the estimate 
based on studies that included diet alone in comparison to 
those in which folate supply was from diet and supple-
ments. This finding is in line with results from a similar 
systematic review of RCTs among women in childbearing 
age and in pregnancy and lactation [29]. Because synthetic 
folate is 1.7 times more bioavailable than naturally occur-
ring folate [14, 37], total dietary folate should be expressed 
as DFE to account for this difference in bioavailability. 
However, for studies that assessed folate intake from the 
diet including the use of supplements, this conversion into 
DFE was done in only 5 out of 12 studies [14, 16, 22, 23, 
32]. Also, some studies used 100–200 μg/day of folic acid 
as a conservative estimate of intake from supplements 
based on supplements available on the market, and added 
that amount without conversion to DFE to total dietary 
folate [18, 19, 25]. Finally, the proportion of regular and 
occasional supplement users varied between 4.8 and 26%, 
with average supplement dose up to 200 μg/day [11, 12, 17, 
18, 22, 25, 27, 29]. This fact along with the lack of standard-
ization in reporting total folate intake as DFE will have af-
fected the estimates and contributed to heterogeneity of 
stratum-specific estimates. In addition, the stronger folate 
intake-status association resulting from natural folate in 
comparison to that from natural folate and folic acid could 
be linked to the property of naturally occurring folate: re-
portedly, it is as effective as or even more effective than 
folic acid in preserving folate status [35].
Studies included in these meta-analyses used a variety 
of analytical methods for measurement of folate status 
markers: 7 for serum/plasma, 5 for RBC folate, and 5 for 
plasma homocysteine. Because there were a small num-
ber of studies that applied the same analytical method per 
stratum for each biomarker, we were able to perform 
stratified meta-analyses or meta-regression only for the 
broad categories of microbiological assay and non-mi-
crobiological assay. This approach was already followed 
in a meta-analysis of folic acid intake-status relationship 
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nificant higher estimates for folate intake-status serum/
plasma relationship when microbiological assay was used 
rather than non-microbiological assay, whereas the esti-
mates for RBC folate did not statistically differ between 
the 2. Our finding that the type of analytical method had 
a considerable influence on the response, confirms the 
expert opinion that comparison of studies that used dif-
ferent assays requires caution, as different analytical 
methods are known to cause up to 30% difference in fo-
late status results [38]. Indeed, future research should 
benefit from methodologically comparable data on folate 
intake and status. 
We postulated that factors that explain heterogeneity 
in plasma/serum and RBC folate could be similar. Since 
plasma/serum and RBC folate yielded similar overall es-
timates, we combined the 22 estimates on serum/plasma 
folate and the 13 estimates on RBC folate in a meta-re-
gression model, with the biomarker medium (serum/
plasma or RBC folate) as an additional covariable. (Given 
that results from the same study are not statistically inde-
pendent, we used studies [13, 14, 16, 23] to get the esti-
mates for red blood folate only.) The biomarker medium 
in fact provided no statistically significant explanation 
(p = 0.82). Our interpretation of this observation is that 
similar factors cause heterogeneity for both biomarkers. 
Studies that were included in this review applied di-
verse dietary assessment methods too. It is another aspect 
that should be taken into consideration when examining 
the heterogeneity between studies, as it is known that di-
etary intake measurement errors differ considerably by di-
etary assessment method [39]. For example, in general, 
FFQs are designed to rank individuals rather than to as-
sess their absolute intake levels. Also, a small number of 
replicates of 24HDR with no adjustment for intra-individ-
ual variability can give different estimates in comparison 
to multiple replicates. The FFQ was the most commonly 
used dietary instrument in this review; it was used to re-
flect folate intake for up to 3 months or 1 year. Stratified 
meta-analysis for the dietary intake method in serum/
plasma and in RBC folate gave different estimates between 
the FFQ subgroup and 24HDR or FR subgroup: the asso-
ciation in FFQ subgroup was statistically and significantly 
weaker for RBC folate and statistically and not significant-
ly stronger in plasma/serum folate when compared to 
24HDR or FR subgroups per each biomarker. Observed 
differences in estimates indicate varying levels of bias as-
sociated with each measurement tool, for example, under-
reporting for 24 h recall, over- or underreporting of im-
portant folate-containing foods by the FFQ, inadequate 
folate values in food tables, different bioavailability of fo-
late from different food products, the seasonality of data 
collection, or perhaps a combination of these conditions 
[40, 41]. For example, the nutrient intakes as from 24HDR 
is adjusted to reflect long-term exposure and, therefore, 
they may be more comparable to status assessed by RBC 
folate than by serum folate [42] as it implies from the re-
sults in this study. We hypothesized that, to some extent, 
the reason for the high heterogeneity in the meta-analysis 
of serum/plasma folate for the studies with FFQ might be 
genetic variation in the 677C→T mutation in the gene, 
which is known to significantly influence concentrations 
of folate status biomarkers at folate intake levels < 250 μg/
day [15]. Because 2 studies provided the information on 
this gene mutation, we performed sensitivity analyses by 
removing the estimates with TT genotypes [15, 17]; how-
ever the heterogeneity remained the same (I2 = 94%). We 
also acknowledge that the estimation of folate intake re-
quires reliable data on food composition. An important 
factor that hampers comparability of the data (between 
studies and across countries) and can be a source of errors 
is the lack of uniformity in food composition databases. 
This issue has been addressed in many past and ongoing 
projects worldwide. For instance, an important conclu-
sion derived from the EFCOSUM project was that it is not 
possible at the present time to make existing food con-
sumption data comparable at the nutrient level [45]. 
Therefore, for the purpose of this study, a problem of ap-
plication of different food composition databases could 
not have been solved. Overall, when the pooled estimates 
from stratified subgroup analysis are analyzed in detail, 
folate matrix is the influencing factor on the overall beta 
for each folate-specific biomarker, in addition to the type 
of analytical method for serum/plasma folate (we were un-
able to do stratified analyses for dietary intake assessment 
and the type of analytical method at homocysteine be-
cause of small study numbers in each subgroup). 
The relationship between folate intake and status in 
adults and the elderly has also been assessed in a meta-
analysis of RCTs [3]. The association in RCTs was stron-
ger than that in the observational studies in this paper, 
that is, for every doubling in folic acid intake, the in-
crease in serum/plasma folate and RBC folate was 63 and 
31% respectively. Another publication by Berti et al. [35] 
based on RCTs in women of reproductive age showed 
relationships for folate in RBCs and for total plasma ho-
mocysteine similar to those reported in the present 
study: 0.33 (95% CI 0.23–0.44) and –0.12 (95% CI –0.15 
to –0.08), respectively, whereas the association for se-
rum/plasma folate was stronger – 0.65 (95% CI 0.39–
0.93) – than that shown by our data. One potential ex-
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planation for larger β in the RCTs could be higher bio-
availabity of folic acid (85% or greater), which appears 
unaltered in the circulation and gives rise to serum/plas-
ma folate in comparison to natural folates (25–50%) 
[43]. On the other hand, our estimates for serum/plasma 
as from subgroup analyses from microbiological assay 
are similar to those from RCTs. Assuming that micro-
biological assay is considered the gold standard for total 
folate measurement in serum [3], it may be that the 
overall pooled estimate for serum/plasma as from this 
paper is underestimated. 
The observed mean folate intake in this review (266 μg/
day) is in line with intakes indicated by individual obser-
vational studies that assessed folate intake in adults and 
elderly in Europe: the mean folate intake for adults and 
elderly in the European Nutrition and Health Report 
(25 countries) ranged from 130 to 370 μg/day in women 
and from 150 to 440 μg/day in men [44], whereas the re-
sults from the EPIC cohort (10 countries) reported 200–
300 μg/day in women and 250–350 μg/day in men [45]. 
The levels of serum/plasma folate reported in a recent 
publication on micronutrient intake and status is Europe 
were 14–23 nmol/L [46], and in the publication by Duffy 
et al. [3], the levels were in the range 6–24 nmol/L and 
this is in line with the range observed in this review (5–
31 nmol/L). 
Thus, mean levels of intake and biomarkers are com-
parable to other studies, whereas their associations are 
heterogeneous. Although this heterogeneity might par-
tially derive from methodological factors (standardiza-
tion to DFE, dietary assessment method, analytical meth-
od used to determine level of status biomarkers), the 
overall estimates are consistent with those of other similar 
dose-response meta-analyses of trials (using synthetic fo-
late) and observational studies among pregnant women. 
Possibly, to some extent, part of the between-study het-
erogeneity might reflect true differences between popula-
tions that average out in the meta-analysis.
Conclusion
This study shows that the quantified statistically sig-
nificant relationships between folate intake and folate 
status biomarkers are similarly positive for serum/plas-
ma and RBC folate and inverse for homocysteine. Be-
cause the ranges of dietary folate intake and serum/plas-
ma folate shown in this review are similar to those re-
ported in other studies conducted involving adults and 
elderly, the estimates shown by this review reflect folate 
intake and serum/plasma folate relationship in these 
population groups. The relative heterogeneity that we 
found between the studies indicates that for getting more 
reliable estimates, future research should take into con-
sideration: (i) known differences in bioavailability be-
tween the natural forms and folic acid from supplements 
and fortified foods and (ii) variability that exists among 
different folate assay methodologies and across different 
laboratories [3]. Nevertheless, this study uses best qual-
ity available data and can be used to study the relation-
ships between folate intake, status and health-related 
outcomes more in depth. Furthermore, reported esti-
mates as from this paper together with those from RCTs 
can serve as a basis for further modeling toward deter-
mining dietary reference values for folate, such as the 
Average Nutrient Requirement (ANR), which vary 
greatly across countries (200–320 μg/day) [47–49]. The 
principle of that methodology has recently been devel-
oped within the EURRECA NoE and is readily available 
[6]. 
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